|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and Development Expense | |
| General and administrative expenses | |
| Total operating expenses | |
| Operating loss from continuing operations | |
| Interest income (expense) (of which an expense of $0, $17 and $27 are with related parties in 2025, 2024 and 2023, respectively) | |
| Change in fair value of convertible securities | |
| Other expense, net | |
| Loss from continuing operations | |
| Net income (loss) from discontinued operations | |
| Net loss | |
| Loss per share attributable to shareholders: | |
| Basic | |
| Diluted | |
| Weighted average Ordinary Shares outstanding – basic | |
| Weighted average Ordinary Shares outstanding – diluted |
Loading...
